Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

West to Host Second-Quarter 2020 Conference Call

EXTON, Pa., July 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2020 financial results before the market opens on Thursday, July 23, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 7789173.

A live broadcast of the conference call will be available at the Company's website, www.westpharma.com, in the "Investors" section. Management will refer to a slide presentation during the call, which will be made available on the day of the call. To view the presentation, select "Presentations" in the "Investors" section of the Company's website.  

An online archive of the broadcast will be available at the site three hours after the live call and will be available through Thursday, July 30, 2020, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International). The conference ID is 7789173.

About West

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2019 sales of $1.84 billion reflect the daily use of more than 100 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.


SOURCE West Pharmaceutical Services, Inc.

These press releases may also interest you

at 15:17
Today, the American Lung Association and Cleveland Clinic announced an educational collaboration to disseminate free, comprehensive resources on COVID-19 care for healthcare providers globally. The resources inform best practices to care for...

at 15:16
A new analysis by Airlines for America (A4A) ? the industry trade group representing major U.S. carriers ? shows which states are experiencing the greatest impact on air service and air-travel demand amid the COVID-19 health crisis....

at 15:15
Vuzix® Corporation , ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, announced today that Vuzix' M400 Smart Glasses are now supported by CARE4D's Telepresenz®, a HIPAA compliant...

at 15:10
NMS Labs is a leading bioanalytical toxicology and forensic sciences laboratory providing esoteric clinical and forensic services to physicians, attorneys, the criminal justice system, clinical reference labs, pharmaceutical companies, and consumer...

at 15:05
NMS Labs, one of the nation's leading forensic science and bioanalytical toxicology laboratories, announced today that Dan T. Monahan is the now President and Chief Executive Officer of the Company. Mr. Monahan will build upon NMS Labs' success and...

at 15:00
SymphonyRM today announced a new premier relationship with Silverline, a Salesforce Platinum Partner, that will leverage SymphonyRM's HealthOS Data Platform combined with Silverline's healthcare implementation standards acquired through more than a...

News published on 9 july 2020 at 06:00 and distributed by: